Publications by authors named "Stephan Fuhrmann"

Claim this Profile
E
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition.
Anna Ossami Saidy, Christophe Peczynski, Catherine Thieblemont, Michael Daskalakis, Marc Wehrli, Stephan Fuhrmann

Hemasphere· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6).
Stephan Fuhrmann, Maike Nickelsen, Justin Hasenkamp, Andreas Hüttmann, Martin Dreyling

Ann Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Stefanie Jilg, Juliana Schwaab, Katja Sockel, Carl C Crodel, Valeska Brueckl, Stephan Fuhrmann

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial.
Fabio Efficace, Michal Kicinski, Corneel Coens, Stefan Suciu, Walter J F M van der Velden, Stephan Fuhrmann

Blood· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Michael Lübbert, Pierre W Wijermans, Michal Kicinski, Sylvain Chantepie, Walter J F M Van der Velden, Stephan Fuhrmann

Lancet Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked skewing of entire T-cell memory compartment occurs only in a minority of CMV-infected individuals and is unrelated to the degree of memory subset skewing among CMV-specific T-cells.
Stephan Fuhrmann, Bernhard Reus, Oliver Frey, Alejandra Pera, Louis J Picker

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of electronic patient-reported outcome assessment in inpatient cancer care: a feasibility study.
Hanna Salm, Leopold Hentschel, Martin Eichler, Daniel Pink, Stephan Fuhrmann

Support Care Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Elias K Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Stephan Fuhrmann

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial.
Hans Salwender, Ahmet Elmaagacli, Maximilian Merz, Kaya Miah, Axel Benner, Stephan Fuhrmann

Leukemia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.
Eva-Maria Klein, Diana Tichy, Hans J Salwender, Elias K Mai, Jan Duerig, Stephan Fuhrmann

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated pulmonary AL amyloidosis associated with lymphoplasmacytic lymphoma.
Snjezana Janjetovic, Jaroslaw Wojciech Augustyniak, Silvia Darb-Esfahani, Clemens Baumann, Stephan Fuhrmann

EJHaem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Stephan Fuhrmann

Blood Adv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Elias K Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Stephan Fuhrmann

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Marc-Andrea Baertsch, Elias K Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Stephan Fuhrmann

Blood Cancer J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.
Lennart Lenk, Michela Carlet, Fotini Vogiatzi, Lea Spory, Dorothee Winterberg, Stephan Fuhrmann

Commun Biol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial.
Hartmut Goldschmidt, Elias K Mai, Jan Dürig, Christof Scheid, Katja C Weisel, Stephan Fuhrmann

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
Mohamad Jawhar, Konstanze Döhner, Sebastian Kreil, Juliana Schwaab, Khalid Shoumariyeh, Stephan Fuhrmann

Leukemia· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.
Stephan Fuhrmann, Richard Schabath, Anja Möricke, Martin Zimmermann, Joachim B Kunz

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.
Saad Akhtar, Silvia Montoto, Ariane Boumendil, Herve Finel, Tamas Masszi, Stephan Fuhrmann

Am J Hematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Diagnosis and Treatment of Multiple Myeloma.
Christian Gerecke, Stephan Fuhrmann, Susanne Strifler, Martin Schmidt-Hieber, Hermann Einsele

Dtsch Arztebl Int· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phenotypic distribution and functional profile of tuberculin-specific CD4 T-cells characterizes different stages of TB infection.
Mathias Streitz, Stephan Fuhrmann, David Thomas, Elizabeth Cheek, Laurel Nomura

Cytometry B Clin Cytom· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporin A and tacrolimus reduce T-cell polyfunctionality but not interferon-γ responses directed at cytomegalovirus.
Stephan Fuhrmann, Raskit Lachmann, Mathias Streitz, Roland Hetzer, Hans-Dieter Volk

Immunology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process.
Valentina Libri, Rita I Azevedo, Sarah E Jackson, Diletta Di Mitri, Raskit Lachmann, Stephan Fuhrmann

Immunology· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination.
Mathias Streitz, Stephan Fuhrmann, Fiona Powell, Ali Quassem, Laurel Nomura

J Infect Dis· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribozyme to TGF-beta1 mRNA abrogates immunosuppressive effects of human colorectal adenocarcinoma HRT-18 cells in vitro and in vivo.
Wolfgang Daniel Schmitt, Antje Siegert, Sandra Stephanie Lach, Stephan Fuhrmann, Anke Kondla

Int J Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis